April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Investigation of Pax6 Function in Mouse Cornea Using an Inducible Deletion Mouse Model, K12rtTA/tetOCre/Pax6flox
Author Affiliations & Notes
  • M.-T. T. Nguyen
    Ophthalmology, University of Cincinnati, Cincinnati, Ohio
  • C.-Y. Liu
    Ophthalmology, University of Cincinnati, Cincinnati, Ohio
  • R. Ashery-Padan
    Dept of Human Molecular Genetics, Tel Aviv University, Tel Aviv, Israel
  • W. W. Y. Kao
    Ophthalmology, University of Cincinnati, Cincinnati, Ohio
  • Footnotes
    Commercial Relationships  M.-T.T. Nguyen, None; C.-Y. Liu, None; R. Ashery-Padan, None; W.W.Y. Kao, None.
  • Footnotes
    Support  NIH EY010556 and EY 013755, Research to Prevent Blindness, Inc. and Ohio Lions Eye Research Foundation
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 354. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.-T. T. Nguyen, C.-Y. Liu, R. Ashery-Padan, W. W. Y. Kao; Investigation of Pax6 Function in Mouse Cornea Using an Inducible Deletion Mouse Model, K12rtTA/tetOCre/Pax6flox. Invest. Ophthalmol. Vis. Sci. 2010;51(13):354.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Study role of Pax6 in K12+ differentiating mouse corneal epithelial cells in vivo.

Methods: : We crossed K12rtTA/rtTA with tetOCre and Pax6flox/flox transgenic mice to ablate Pax6 in corneal epithelium of triple transgenic animal, K12rtTA/rtTA/tetOCre/Pax6flox/flox upon doxycycline induction. Pax6 was conditionally deleted in K12+ differentiating cells in the corneal epithelium of K12rtTA/rtTA/tetOCre/Pax6flox/flox and K12rtTA/rtTA/tetOCre/Pax6flox/+ mice by feeding them 1g/kg doxycycline chow. Inducible deletion of Pax6 in corneal epithelial cells was performed starting during embryonic development prior to birth, 3 weeks and 6 weeks after birth and ending at 14-15 weeks (three treatment durations total). The effect of homozygous (Pax6ced/ced) or heterozygous (Pax6ced/+) corneal epithelial-specific Pax6 deletion was examined by stereomicroscope. Corneal epithelium integrity was examined by immunohistochemistry. All reported research was conducted in compliance with the ARVO statement for the Use of Animals in Ophthalmic and Vision Research.

Results: : For mice with embryonic Dox-induced Pax6 deletion, the corneas of Pax6ced/ced developed corneal haze evident at eight weeks old, earlier than haze seen in corneas of Pax6ced/+. A change in epithelial cell morphology was already seen at three weeks, as indicated by phalloidin staining. The corneas of some triple transgenic mice induced at 3 weeks-old also developed corneal haze at 14 wks, but most of mice induced at 6 weeks-old did not develop corneal haze.

Conclusions: : The K12rtTA/rtTA/tetOCre/Pax6flox/flox transgenic line allows us to study the functional role of Pax6 in the cornea independent of Pax6 effects from other tissues such as the lens, ciliary bodies and iris. Surprisingly, we found that lack of Pax6 expression in K12+ cells in adult mice did not affect cornea clarity in most mice, suggesting that Pax6’s contribution to maintenance of corneal epithelial homeostasis may be in progenitor/basal cells.

Keywords: cornea: basic science • cornea: epithelium • genetics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×